IZEN PHARMA KOREA: PROFESSIONAL COMPETENCE,
PRECISION AND EXTRAORDINARY RESULTS
Allies in the field of reproductive medicine and, specifically, in the distribution of progesterone in liquid solution, IBSA’s South Korean collaborators from IZEN Pharma Korea are a strategic partner in the Asian country. In South Korea, the approval process for pharmaceutical products is very complex. But the bureaucratic slowdowns were soon replaced by the excellent results: from the beginning of the collaboration (in 2019) to date, the progesterone turnover has grown exponentially, up to sevenfold the initial figures. The progesterone sold in South Korea is equal to 20% of the entire IBSA sales for this product in 2021, a significant figure, both for its numerical weight and for the significance it assumes in the reference market. IZEN Pharma Korea is the only distributor in South Korea able to offer progesterone in a non-oily liquid solution, and this represents a new and pioneering approach in a market where tablets are still very common.
On May 9, the South Korean delegation of sales reps visited the IBSA plants where progesterone is produced. “When we started our collaboration with IBSA, we accepted a great challenge: to introduce in South Korea a major innovation such as liquid progesterone”, said Jung-Yong Ko, CEO of IZEN Pharma Korea. “Thanks to our mutual trust and a constant commitment, we were able to achieve excellent results. We are excited to continue this fruitful collaboration, by expanding the portfolio of IBSA products to be distributed in South Korea, while welcoming all the new challenges that may arise”.